This inventor holds 6 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Douglas H. Yamada: Innovator in Prostate Cancer Treatment
Introduction
Douglas H. Yamada is a prominent inventor based in Philadelphia, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of prostate cancer. With a total of 6 patents to his name, Yamada's work is recognized for its innovative approaches and potential impact on patient care.
Latest Patents
Yamada's latest patents focus on methods of treating prostate cancer. Specifically, he has disclosed methods that involve administering niraparib to a human in need thereof. This innovative approach aims to improve treatment outcomes for patients suffering from this condition.
Career Highlights
Douglas H. Yamada is currently associated with Janssen Pharmaceutica NV, a company known for its commitment to developing advanced medical solutions. His work at Janssen has allowed him to explore new avenues in cancer treatment, contributing to the company's reputation as a leader in pharmaceutical innovation.
Collaborations
Yamada has collaborated with notable colleagues in his field, including Marco Gottardis and Rebecca Hawkins. These partnerships have fostered a collaborative environment that enhances the development of effective treatment methods.
Conclusion
Douglas H. Yamada's contributions to prostate cancer treatment exemplify the importance of innovation in medicine. His patents and collaborations reflect a dedication to improving patient outcomes and advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile